Shaker R Dakhil - JoVE Visualize

Showing results (81-90 of 114) with videos related to

Pageof 12

Sort By:

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009

Multicenter randomized phase II study of weekly or twice-weekly bortezomib plus rituximab in patients with relapsed or refractory follicular or marginal-zone B-cell lymphomaSven de Vos, André Goy, Shaker R Dakhil, et al.

British Journal of Clinical Pharmacology|February 10, 2016

Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226Daniel L Hertz, William E Barlow, Kelley M Kidwell, et al.

Cancer|March 15, 2012

Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1Brandi N Reeves, Shaker R Dakhil, Jeff A Sloan, et al.

Cancer|May 25, 2005

Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trialCharles L Loprinzi, Ralph Levitt, Debra L Barton, et al.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 3, 2015

Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP studyAnita R Peoples, Peter W Bushunow, Sheila N Garland, et al.

The Oncologist|March 11, 2022

Liquid Biopsy-based Precision Therapy in Patients with Advanced Solid Tumors: A Real-world Experience from a Community-based Oncology PracticeKhalil Choucair, Bassam Ibrahim Mattar, Quoc Van Truong, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2019

A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 StudyErin L Schenk, Sumithra J Mandrekar, Grace K Dy, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2005

Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group StudyEvanthia Galanis, Jan C Buckner, Matthew J Maurer, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2018

Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort StudyMichelle C Janelsins, Charles E Heckler, Luke J Peppone, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2006

Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321Bart Barlogie, Robert A Kyle, Kenneth C Anderson, et al.

Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:

Pageof 12

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009

Multicenter randomized phase II study of weekly or twice-weekly bortezomib plus rituximab in patients with relapsed or refractory follicular or marginal-zone B-cell lymphomaSven de Vos, André Goy, Shaker R Dakhil, et al.

British Journal of Clinical Pharmacology|February 10, 2016

Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226Daniel L Hertz, William E Barlow, Kelley M Kidwell, et al.

Cancer|March 15, 2012

Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1Brandi N Reeves, Shaker R Dakhil, Jeff A Sloan, et al.

Cancer|May 25, 2005

Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trialCharles L Loprinzi, Ralph Levitt, Debra L Barton, et al.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 3, 2015

Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP studyAnita R Peoples, Peter W Bushunow, Sheila N Garland, et al.

The Oncologist|March 11, 2022

Liquid Biopsy-based Precision Therapy in Patients with Advanced Solid Tumors: A Real-world Experience from a Community-based Oncology PracticeKhalil Choucair, Bassam Ibrahim Mattar, Quoc Van Truong, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2019

A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 StudyErin L Schenk, Sumithra J Mandrekar, Grace K Dy, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2005

Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group StudyEvanthia Galanis, Jan C Buckner, Matthew J Maurer, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2018

Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort StudyMichelle C Janelsins, Charles E Heckler, Luke J Peppone, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2006

Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321Bart Barlogie, Robert A Kyle, Kenneth C Anderson, et al.

Pageof 12